Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events

被引:26
|
作者
Pagnamenta, Alberto [1 ,2 ]
Rabito, Giovanni [3 ]
Arosio, Alessandra [3 ]
Perren, Andreas [1 ,2 ]
Malacrida, Roberto [1 ,2 ]
Barazzoni, Fabrizio [4 ]
Domenighetti, Guido [1 ,2 ]
机构
[1] EOC, Dept Intens Care Med, Intens Care Units Reg Hosp Mendrisio, Bellinzona, Switzerland
[2] EOC, Dept Intens Care Med, Intens Care Units Reg Hosp Mendrisio, Lugano, Switzerland
[3] Reg Hosp Locarno, Div Qual Improvement & Risk Management, Locarno, Switzerland
[4] EOC, Med Area Unit, Bellinzona, Switzerland
来源
关键词
Adverse events; Medical errors; Patient safety; Quality improvement; Intensive care; Reliability; PATIENT SAFETY; QUALITY IMPROVEMENT; MEDICATION ERRORS; PHARMACISTS; FRAMEWORK; OUTCOMES;
D O I
10.1186/2110-5820-2-47
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Adverse events (AEs) frequently occur in intensive care units (ICUs) and affect negatively patient outcomes. Targeted improvement strategies for patient safety are difficult to evaluate because of the intrinsic limitations of reporting crude AE rates. Single interventions influence positively the quality of care, but a multifaceted approach has been tested only in selected cases. The present study was designed to evaluate the rate, types, and contributing factors of emerging AEs and test the hypothesis that a multifaceted intervention on medication might reduce drug-related AEs. Methods: This is a prospective, multicenter, before-and-after study of adult patients admitted to four ICUs during a 24-month period. Voluntary, anonymous, self-reporting of AEs was performed using a detailed, locally designed questionnaire. The temporal impact of a multifaceted implementation strategy to reduce drug-related AEs was evaluated using the risk-index scores methodology. Results: A total of 2,047 AEs were reported (32 events per 100 ICU patient admissions and 117.4 events per 1,000 ICU patient days) from 6,404 patients, totaling 17,434 patient days. Nurses submitted the majority of questionnaires (n = 1,781, 87%). AEs were eye-witnessed in 49% (n = 1,003) of cases and occurred preferentially during an elective procedure (n = 1,597, 78%) and on morning shifts (n = 1,003, 49%), with a peak rate occurring around 10 a. m. Drug-related AEs were the most prevalent (n = 984, 48%), mainly as a consequence of incorrect prescriptions. Poor communication among caregivers (n = 776) and noncompliance with internal guidelines (n = 525) were the most prevalent contributing factors for AE occurrence. The majority of AEs (n = 1155, 56.4%) was associated with minimal, temporary harm. Risk-index scores for drug-related AEs decreased from 10.01 +/- 2.7 to 8.72 +/- 3.52 (absolute risk difference 1.29; 95% confidence interval, 0.88-1.7; p < 0.01) following the introduction of the intervention. Conclusions: AEs occurred in the ICU with a typical diurnal frequency distribution. Medication-related AEs were the most prevalent. By applying the risk-index scores methodology, we were able to demonstrate that our multifaceted implementation strategy focused on medication-related adverse events allowed to decrease drug related incidents.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Olfactory-Related Adverse Events: An Analysis of the Food and Drug Administration Adverse Events Reporting System
    Minutello, Katrina M.
    Lofgren, Daniel H.
    Lenkeit, Christopher P.
    Emmer, Eriel
    Rivera, Olga Santiago
    Hasan, Md Sakibur
    Downs, Asha
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 170 (05) : 1296 - 1306
  • [42] Evaluation of adverse drug reactions in medical intensive care units
    Sojin Park
    Yongwon In
    Gee young Suh
    Kieho Sohn
    Eunyoung Kim
    European Journal of Clinical Pharmacology, 2013, 69 : 119 - 131
  • [43] Evaluation of adverse drug reactions in medical intensive care units
    Park, Sojin
    In, Yongwon
    Suh, Gee Young
    Sohn, Kieho
    Kim, Eunyoung
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (01) : 119 - 131
  • [44] Incidence and nature of adverse drug events in paediatric intensive care units: A prospective multicentre study
    Alghamdi, Anwar A.
    Keers, Richard N.
    Sutherland, Adam
    Hann, Mark
    Gray, Jennifer
    Mason, Graham
    Isaac, Rhian E.
    Ashcroft, Darren M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2213 - 2222
  • [45] Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department
    Hohl, CM
    Dankoff, J
    Colacone, A
    Afilalo, M
    ANNALS OF EMERGENCY MEDICINE, 2001, 38 (06) : 666 - 671
  • [46] Towards the Integration of Precision Medicine in Psychiatric Care Delivery: Evaluating the Impact of Clinical Guidelines on Drug-Related Adverse Events
    Yang, Jingwen
    Mishra, Anant
    Sinha, Kingshuk K.
    JOURNAL OF OPERATIONS MANAGEMENT, 2025,
  • [47] THE ROLE OF DRUG-RELATED ADVERSE PATIENT EVENTS IN ACUTE HOSPITAL ADMISSIONS
    MITENKO, PA
    NAUJOKS, SR
    SITAR, DS
    AOKI, FY
    MONTGOMERY, PR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 210 - 210
  • [48] IMPACT OF DEPRESSION AND ANXIETY ON PERCEPTION OF DRUG-RELATED ADVERSE EVENTS AND QUALITY OF LIFE IN PATIENTS WITH EPILEPSY
    Kuzmanova, Rumyana
    Stefanova, Irina
    Kolev, Pencho
    Stambolieva, Katerina
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2017, 70 (07): : 1039 - 1048
  • [49] Adverse events with arterial catheters in intensive care units: a scoping review
    Mariano-Gomes, P. M.
    Ouverney-Braz, A.
    Oroski-Paes, G.
    ENFERMERIA INTENSIVA, 2024, 35 (04): : 410 - 427
  • [50] Newly identified adverse events of enzalutamide using the food and drug administration adverse event reporting system
    Wang, Xin
    Chang, Lina
    Li, Zhenhua
    Jiang, Yuanfang
    Chen, Yue
    Jia, Xinli
    Wang, Qiye
    Ren, Xiaolu
    Ma, Zhifang
    Zhang, Wei
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (11) : 1099 - 1103